The choice of antibiotics in uncomplicated cystitis: Application of the 'system of objectified judgement analysis' (SOJA) method;Keuze van antibiotica bij ongecompliceerde cystitis; toepassing van de 'system of objectified judgement analysis'(SOJA)-methode

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 49, 1999, Pages 2466-2471

  Janknegt, R ^a   Van Den Broek, P J ^b   Kullberg, B J ^c   Stobberingh, E ^d  

^a Zuyderland Medical Centre   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ARTICLE; CYSTITIS; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; HUMAN; SLOW DRUG RELEASE;

ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, URINARY; CYSTITIS; DELAYED-ACTION PREPARATIONS; FLUOROQUINOLONES; FOSFOMYCIN; HUMANS; NITROFURANTOIN; TRIMETHOPRIM;

EID: 0033524167     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Centraal Begeleidingsorgaan voor de Intercollegiale Toetsing (CBO). Het syndroom van de acute pijnlijke frequente mictie en de patiënt met een langdurige verblijfkatheter. Utrecht: CBO; 1988.
2. Janknegt R, Steenhoek A. The System of Objectified Judgement Analysis (SOJA). A tool in rational drug selection for formulary inclusion. Drugs 1997;53:550-62.
3. Janknegt R. Antimicrobial agents disease and pharmacokinetics. Amsterdam: Reed Healthcare; 1994.
4. Hansten PD, Horn JR. Drug Interactions and updates. Malvern: Lea & Febiger; 1996.
5. Trienekens T, Stobberingh E, Beckers F, Knottnerus A. The antibiotic susceptibility patterns of uropathogens isolated from general practice patients in southern Netherlands. J Antimicrob Chemother 1994;33:1064-6.
6. Micromedex. International HealthCare Series, Vol 100, Eaglewood, Colo.: Micromedex; 1999.
7. Patel SS, Balfour JA, Bryson HM. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs 1997;53:637-56.
8. Fuchs PC, Barry AL, Brown SD. Fosfomycin tromethamine susceptibility of outpatient urine isolates of E. coli and E. faecalis from ten North American medical centres by three methods. J Antimicrob Chemother 1999;43:137-40.